FMCG major, Hindustan Lever Limited (HLL), has recorded a 29% jump in bottomline in its 1QFY02. The jump in bottomline was largely aided by an extraordinary income of Rs 226 m on account of profit arising from the transfer of interest in the Animal Feeds business to the Godrej group. If we exclude this extraordinary income, the net profit growth is around 20.7%.
Operating Profit (EBDIT)
Operating Profit Margin (%)
Profit before Tax & extraordinary income
Profit after Tax/(Loss)
Net profit margin (%)
No. of Shares (eoy) (m)
Earnings per share*
Current P/e ratio
The turnover growth of the company was also not anything to write home about. During the March quarter, HLL recorded a marginal 1.1% growth in sales, which is low compared to its sales growth 4QFY01 (4.6% in 2QFY01, 0.4% in 3QFY01 and 6% in 4QFY01). Other income grew 13.5% reflecting efficient treasury management of surplus funds.
The results include an estimated business restructuring cost of Rs 62.5 m charged in the quarter, compared to Rs 300 m in the same quarter last year.
HLL's domestic FMCG product sales grew modestly. In the Home and Personal Care business, fabric wash grew by 6.6% and skin care grew by 10.6%. Home Care continued its strong growth record (up 18.2%) . While the overall personal wash sales declined (down 6%), sales of power brands (read part of key profitable 30 brands) in this category grew by 5%. Hair category sales were flat while oral care sales declined by 7.8%.
Surf, Rin, Wheel
Lakme, Pond's, Fair & Lovely
Lux, Lifebouy, Liril
In the Foods business, HLL witnessed a decline in packet tea sales (down 13.9%) due to planned rationalisation of the unviable products in the portfolio. Oils and fats (up 18.5%) and coffee (up 9.5%) recorded strong growth. During the quarter, HLL has reorganised the foods distribution system by integrating the sales system of branded staples and International Bestfoods Limited with the distribution system for culinary products (namely 'Kissan') and oils and fats. HLL maintains that this is expected to bring significant synergies in the longer term through improved reach for all foods products as well as provide a critical mass for the same. The sales of culinary products (down 12.3%) and branded staples (down 13.5%) declined during the quarter due to the reorganisation mentioned above. Ice cream sales were flat.
Taj Mahal, Lipton, Brooke Bond
Kissan sauces, noodles
Annapurna Atta, salt
Oil & fats
Faced with difficult market conditions and a slowdown in turnover growth HLL had announced at an analyst meet earlier that it is looking to reduce its number of brands from 110 plus to 30 in the next few years. This was because these 30 brands contributed more than 100% to its bottomline. The other odd 80 brands ate away at its profits. Added to that the company had identified 4 new product segments for giving an impetus to its turnover growth. These include over the counter healthcare products, water, confectionery and business through the internet.
In a related development the company has decided to merge International Bestfoods and Aviance with itself. Earlier the company had spun off its fragrance division to a joint venture with ICI and Quest International.
At the current market price of Rs 217, HLL is trading at 35.2 times its annualised 1QFY02 earnings. Concerns about its slowing topline growth has adversely affected the company's stock price in the past few months. The company's market cap to sales ratio of 4.5 times is still below its historic 5-6 times.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India. Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407